Tovetumab
Tovetumab
Tovetumab (/toʊˈvɛtjʊmæb/) is a monoclonal antibody designed for the treatment of cancer. It is a type of immunotherapy that targets specific cells to stimulate the body's immune system to attack those cells.
Etymology
The name "Tovetumab" follows the INN naming convention for monoclonal antibodies, with the suffix "-mab" indicating it is a monoclonal antibody. The prefix "Tove-" does not have a specific meaning in this context.
Mechanism of Action
Tovetumab works by binding to a specific protein found on the surface of cancer cells. This binding triggers the immune system to attack and destroy the cancer cells. The specific protein that Tovetumab targets is not currently known.
Related Terms
See Also
External links
- Medical encyclopedia article on Tovetumab
- Wikipedia's article - Tovetumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski